NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

PostScript Primary Care - June 2014

Posted: June 26, 2014.
Category - Medicines Update Primary Care
Tagged with - Prescribing Antiplatelets

To view this bulletin in PDF format click here.

This bulletin contains information on:

  • Tramadol
  • Gluten-Free food service
  • Domperidone
  • Dual Antiplatelet Therapy
  • Patient Group Directions

Read More...

Formulary News (June 2014)

Posted: June 16, 2014.
Category - Formulary Update

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on 9th June. The Formulary decisions from that meeting are summarised in this post

Read More...

24: Oral NSAIDs

Posted: June 13, 2014.
Category - Medicines Update Extra

 Oral NSAIDs - An Update

** This bulletin supersedes No. 22 **

  • There is considerable variation in individual response and tolerance to NSAIDs, but little difference in anti-inflammatory activity.
  • All NSAIDs should be avoided if possible in patients with a history of vascular disease, a high risk of cardiovascular disease (CVD), or gastrointestinal (GI) risk factors.
  • Treatment choice depends on individual response, risk factors and adverse effects, particularly GI and cardiovascular (CV) complications.
  • The lowest effective dose to control the patient’s symptoms, for the shortest duration possible, should be used.
  • The preferred non-selective NSAIDs are low dose ibuprofen or naproxen. A proton pump inhibitor (PPI) is required depending on GI risk.

Read More...

PostScript Community Pharmacy June 2014

Posted: June 11, 2014.
Category - Medicines Update Community Pharmacy

The latest edition is available here. Articles cover the following topics: NHS Healthcare provision to Police Custody Suites...

Read More...

PostScript Acute 17 (June 2014)

Posted: May 27, 2014.
Category - Medicines Update Acute
Tagged with - Biologics Dabigatran Osteoporosis Antimicrobial Prescribing Anticoagulants Medication incidents gentamicin

In this issue:

  • Pharmacy prioritisation and referral
  • Novel oral anticoagulants (NOACs) in atrial fibrillation: Update
  • TNF alpha inhibitors: risk of tuberculosis
  • Guideline news
  • Learning from incidents: warfarin follow-up post-discharge
  • Gentamicin prescription chart: updated version
  • Reminder: how to safely prescribe weekly alendronic acid

Information included is specific to the use of medicines in the adult setting.

Read More...

PostScript Primary Care - May 2014

Posted: May 13, 2014.
Category - Medicines Update Primary Care
Tagged with - Opioids Benzodiazepines Anticoagulants Methotrexate Parkinson's disease

To view this bulletin in PDF format click here.

This bulletin contains information on:

  • Low Dose Naltrexone
  • New oral anticoagulants
  • Chronic non-malignant pain opioid guidelines - updated
  • Reducing prescribing of hypnotics and anxiolytics
  • Methotrexate and trimethoprim interaction
  • Depression treatment guideline
  • Vitamin B12 Injections

 

Read More...

Formulary News (Apr 2014)

Posted: May 06, 2014.
Category - Formulary Update

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on 28th April. The Formulary decisions from that meeting are summarised in this post

Read More...

PostScript 81 PDF (May 2014)

Posted: May 05, 2014.
Category - Medicines Update

This edition can be accessed in PDF format here and contains articles on:   Novel oral anticoagulant update New oral products for multiple sclerosis Tramadol to become controlled drug ...

Read More...

Novel Oral Anticoagulants (NOACs): update

Posted: May 05, 2014.
Category - Medicines Update
Tagged with - Anticoagulants

  Inclusion of the NOACs (dabigatran, rivaroxaban, apixaban) on the NHSGGC Formulary is established for existing patients with non-valvular atrial fibrillation (AF) who are intolerant of, or poor...

Read More...

New oral therapies for Multiple Sclerosis

Posted: May 05, 2014.
Category - Medicines Update
Tagged with - SMC

It is exciting times in the treatment of Multiple Sclerosis (MS) with the approval of two new oral therapies for the treatment of the relapsing remitting form of the disease; dimethyl fumarate and teriflunomide. There has bee...

Read More...